HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katharine Abbott-Banner Selected Research

ensifentrine

10/2019Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
11/2018The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katharine Abbott-Banner Research Topics

Disease

1Asthma (Bronchial Asthma)
10/2019
1Chronic Obstructive Pulmonary Disease (COPD)
11/2018

Drug/Important Bio-Agent (IBA)

2Bronchodilator Agents (Bronchodilators)IBA
10/2019 - 11/2018
2Albuterol (Salbutamol)FDA LinkGeneric
10/2019 - 11/2018
2ensifentrineIBA
10/2019 - 11/2018
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
10/2019 - 11/2018
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
11/2018